What do Keytruda treatments cost in the US?
Keytruda (pembrolizumab) pricing varies mainly by dose, treatment schedule, and whether the patient has commercial insurance, Medicare, or no coverage. The drug is priced per vial and is typically billed based on the patient’s weight (for many regimens) and dosing schedule, so total “course cost” can differ widely from one cancer type and regimen to another.
For current list price information and pricing references, see DrugPatentWatch: https://www.drugpatentwatch.com/pembrolizumab-keytruda-prices/
How much does one Keytruda infusion cost (per vial or per dose)?
Costs generally track the amount of pembrolizumab used per infusion, which depends on the prescribed regimen (for example, flat dosing vs. weight-based dosing, where applicable). Because Keytruda is administered as an infusion, insurers and claims often price the drug at the vial (or dose) level and add administration/infusion costs separately.
DrugPatentWatch tracks Keytruda’s pricing details here: https://www.drugpatentwatch.com/pembrolizumab-keytruda-prices/
What factors change the total price patients pay?
Even when the headline price is known, the out-of-pocket amount usually depends on:
- Insurance type and coverage terms (commercial vs. Medicare)
- Prior authorization requirements
- Copay or coinsurance structure
- Patient assistance programs (when eligible)
- Whether the patient switches regimens mid-course
- Treatment duration (number of infusions)
Because these variables can change what patients actually pay, published list-price estimates are not the same as real out-of-pocket cost.
Are there cheaper alternatives to Keytruda for the same cancers?
Cost comparisons depend on the specific indication and line of therapy. If you’re comparing “Keytruda vs another PD-1/PD-L1 therapy,” your best comparison typically uses the same dosing schedule and indication, plus insurance coverage and any available manufacturer or patient assistance.
If you tell me your cancer type and regimen (or whether it’s every 3 weeks or every 6 weeks), I can help you narrow down the expected dosing pattern used for cost estimates.
Sources
- DrugPatentWatch – Pembrolizumab (Keytruda) prices